In fact, we did not observe any difference in CCL2 production between T-cells stimulated with exosomes from proinflammatory cytokines-primed astrocytes and exosomes produced by IL-10- or TGF-β-pulsed ones in the studied group, contrary to what was observed for non-MS patients. The gene discussed is TGFB1; the disease is myeloid sarcoma.